AU3751689A - Vector for secretion of proteins directly into periplasm or culture medium - Google Patents

Vector for secretion of proteins directly into periplasm or culture medium

Info

Publication number
AU3751689A
AU3751689A AU37516/89A AU3751689A AU3751689A AU 3751689 A AU3751689 A AU 3751689A AU 37516/89 A AU37516/89 A AU 37516/89A AU 3751689 A AU3751689 A AU 3751689A AU 3751689 A AU3751689 A AU 3751689A
Authority
AU
Australia
Prior art keywords
periplasm
secretion
vector
culture medium
proteins directly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37516/89A
Inventor
Sankar Adhya
Vijay Chaudhary
David Fitzgerald
Ira Pastan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Commerce
Original Assignee
US Department of Health and Human Services
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Government filed Critical US Department of Health and Human Services
Publication of AU3751689A publication Critical patent/AU3751689A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/495Transforming growth factor [TGF]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/55Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/61Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU37516/89A 1988-05-09 1989-05-04 Vector for secretion of proteins directly into periplasm or culture medium Abandoned AU3751689A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19201388A 1988-05-09 1988-05-09
US192013 1988-05-09

Publications (1)

Publication Number Publication Date
AU3751689A true AU3751689A (en) 1989-11-29

Family

ID=22707875

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37516/89A Abandoned AU3751689A (en) 1988-05-09 1989-05-04 Vector for secretion of proteins directly into periplasm or culture medium

Country Status (4)

Country Link
EP (1) EP0422049A4 (en)
AU (1) AU3751689A (en)
IL (1) IL90190A0 (en)
WO (1) WO1989010971A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2084992A1 (en) * 1990-06-25 1991-12-26 Osi Pharmaceuticals, Inc. Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof
US5571894A (en) * 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
US5939531A (en) * 1991-07-15 1999-08-17 Novartis Corp. Recombinant antibodies specific for a growth factor receptor
CA2077277A1 (en) * 1991-09-09 1993-03-10 John J. Donnelly Cellular immunity vaccines from bacterial toxin-antigen conjugates
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
EP2327718B1 (en) 2003-11-21 2016-03-23 Pfenex, Inc. Improved expression systems with SEC-system secretion
JP2008507294A (en) 2004-07-26 2008-03-13 ダウ グローバル テクノロジーズ インコーポレイティド Method for improved protein expression by strain genetic manipulation
US7579005B2 (en) 2005-11-28 2009-08-25 E. I. Du Pont De Nemours And Company Process for recombinant expression and purification of antimicrobial peptides using periplasmic targeting signals as precipitable hydrophobic tags
KR101491867B1 (en) 2007-01-31 2015-02-10 피페넥스 인크. Bacterial leader sequences for increased expression
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
JP5444553B2 (en) 2007-04-27 2014-03-19 フェネックス インコーポレイテッド Methods for rapidly screening microbial hosts to identify specific strains with improved yield and / or quality of heterologous protein expression
US8932586B2 (en) 2011-09-06 2015-01-13 Intrexon Corporation Modified forms of Pseudomonas exotoxin A
AU2014248768A1 (en) 2013-03-12 2015-09-24 Massachusetts Eye And Ear Infirmary Modified mullerian inhibiting substance (MIS) proteins and uses thereof for the treatment of diseases
CA3151082A1 (en) 2013-12-11 2015-06-18 The General Hospital Corporation Use of mullerian inhibiting substance (mis) proteins for contraception and ovarian reserve preservation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892827A (en) * 1986-09-24 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects

Also Published As

Publication number Publication date
EP0422049A4 (en) 1991-11-13
EP0422049A1 (en) 1991-04-17
WO1989010971A1 (en) 1989-11-16
IL90190A0 (en) 1989-12-15

Similar Documents

Publication Publication Date Title
AU1482488A (en) Leader sequences for the production of recombinant proteins
AU7865591A (en) Method and means for extending the host range of insecticidal proteins
AU7400391A (en) Method of using bar1 for secreting foreign proteins
AU2650988A (en) Vectors and compounds for direct expression of activated human protein c
AU7869891A (en) Novel enzyme preparations and methods for their production
AU4257389A (en) Method for cultivation of bacteria
AU7873187A (en) Method of culturing leukocytes
AU3533689A (en) Tight binding of proteins to surfaces
AU3751689A (en) Vector for secretion of proteins directly into periplasm or culture medium
AU2885489A (en) Enzymatic hydrolysis of proteins
AU7130891A (en) Vectors and compounds for expression of zymogen forms of human protein c
AU3460289A (en) Novel protein, sequences containing the gene therefore, vectors, methods of preparation and use
AU7474787A (en) Secretion of heterologous proteins from yeast
AU1652888A (en) Fibrinolytic proteins
FI921059A0 (en) Procedure for secretion of yeast beneficial proteins
AU3718484A (en) Novel human interferon-`` polypeptide derivative
AU5602394A (en) Chimeric blood coagulation proteins
AU4584193A (en) Method of stabilizing hygral expansion of protein fiber product
AU8059391A (en) Method of making peptides
AU4927390A (en) Fusion proteins
AU2732988A (en) Vectors and compounds for expression of zymogen forms of human protein c
AU3159784A (en) Insuliin-Potentiating peptides from human growth hormome
AU3608589A (en) Expression vectors for the preparation of infused proteins in microorganisms
AU4805093A (en) Methods for treatment of enzyme preparations
AU7175591A (en) Novel and improved technology for preservation of organs for transplantation